Last reviewed · How we verify
3. Reversibility test with salbutamol
Salbutamol, a short-acting β2-adrenergic agonist, is used for the rapid relief of bronchospasm in asthma and COPD. It is being evaluated in multiple clinical trials to assess its efficacy and safety in various respiratory conditions.
At a glance
| Generic name | 3. Reversibility test with salbutamol |
|---|---|
| Sponsor | Commissariat A L'energie Atomique |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Viral upper respiratory tract infection
- Upper respiratory tract infection
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: